Back to mobile site

More on ALLO

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (7.0 Score)

Upcoming Events

- Earnings (10/30/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Allogene Therapeutics (NQ:ALLO)
Delayed: 2.05 +0.07 (3.54%)
Prev. Close $1.98  
Open$1.96 
52 Wk High$ 
52 Wk Low$ 
Day High$2.08 
Day Low$1.92 
P/E N/A  
EPS$ 
Volume4,605,159 

Friends, Peers and Foes (?): ALCLS, CLLS, CHRS, ELVN, ONCY (more...)

Aug 14, 2026 04:34 PM Form SCHEDULE 13G/A Allogene Therapeutics, Filed by: Frazier Life Sciences Public Fund, L.P.
Aug 12, 2026 04:40 PM Allogene Therapeutics, Inc. (ALLO) Tops Q2 EPS by 4c
Aug 12, 2026 04:30 PM Allogene Therapeutics (ALLO) files $500M mixed shelf
Aug 12, 2026 04:23 PM Form S-3 Allogene Therapeutics,
Aug 12, 2026 04:18 PM Form 10-Q Allogene Therapeutics, For: Jun 30
Aug 12, 2026 04:13 PM Form 8-K Allogene Therapeutics, For: Aug 12
Aug 12, 2026 04:05 PM Allogene Therapeutics Reports Second Quarter 2026 Financial Results and Business Update
Aug 7, 2026 08:21 PM Form SCHEDULE 13G/A Allogene Therapeutics, Filed by: Belldegrun Arie
Aug 7, 2026 08:33 AM Form SCHEDULE 13G Allogene Therapeutics, Filed by: STATE STREET CORP
Aug 4, 2026 08:30 AM Allogene Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update
View All Articles

Entities mentioned with ALLO

View All Entities